Mefloquine versus quinine plus sulphalene-pyrimethamine (metakelfin) for treatment of uncomplicated imported falciparum malaria acquired in Africa

We conducted a multicenter, randomized, open-label trial to compare mefloquine with a 3-day quinine plus sulphalene-pyrimethamine (SP) regimen for the treatment of imported uncomplicated malaria acquired in Africa. The end points of the study were efficacy, tolerability, and length of hospital stay. From July 1999 to February 2003, 187 patients were enrolled in five centers in Italy, of whom 93 were randomized to receive mefloquine (the M group) and 94 were randomized to receive quinine plus SP (the QSP group). Immigrants and visiting relatives and friends represented 90% of the cases and were mainly from western African countries. A slightly increased proportion of cases in the QSP group had abnormal alanine aminotransferase levels at the baseline. The early cure rate was similar in the two groups: 98.9% (confidence interval [CI] = 97 to 100%) in the M group and 96.8% (CI = 93 to 100%) in the QSP group. The extended follow-up was completed by 135 subjects (72.2%), and no case of recrudescence was detected. There were no differences in the parasite clearance time, but patients in the M group had shorter mean fever clearance time (35.9 h versus 44.4 h for the QSP group; P = 0.05) and a shorter mean hospital stay (3.9 days versus 4.6 days for the QSP group; P = 0.007). The overall proportions of reported side effects were similar in the two groups, but patients in the M group had a significantly higher rate of central nervous system disturbances (29.0% versus 9.6% for the QSP group; P < 0.001).

Medienart:

Artikel

Erscheinungsjahr:

2005

Erschienen:

2005

Enthalten in:

Zur Gesamtaufnahme - volume:49

Enthalten in:

Antimicrobial agents and chemotherapy - 49(2005), 2 vom: 26. Feb., Seite 663-7

Sprache:

Englisch

Beteiligte Personen:

Matteelli, Alberto [VerfasserIn]
Saleri, Nuccia [VerfasserIn]
Bisoffi, Zeno [VerfasserIn]
Gregis, Giampietro [VerfasserIn]
Gaiera, Giovanni [VerfasserIn]
Visonà, Raffaella [VerfasserIn]
Tedoldi, Simona [VerfasserIn]
Scolari, Carla [VerfasserIn]
Marocco, Stefania [VerfasserIn]
Gulletta, Maurizio [VerfasserIn]

Themen:

81247-66-7
A7V27PHC7A
Antimalarials
Clinical Trial
Comparative Study
Drug Combinations
Journal Article
Mefloquine
Metakelfin
Multicenter Study
Pyrimethamine
Quinine
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Sulfalene
T6BL4ZC15G
TML814419R
Z3614QOX8W

Anmerkungen:

Date Completed 29.03.2005

Date Revised 13.11.2018

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM15333083X